full
border
#666666
https://www.arboretumvc.com/wp/wp-content/themes/zap-installable/
https://www.arboretumvc.com/wp/
#ffffff
style1

Archive for October, 2014

07
Oct

Cardiac Dimensions® announced the addition of $8.5 million to its previously announced financing. Arboretum Ventures, a Michigan-based venture capital firm specializing in the healthcare sector, joined an international syndicate of institutional investors from Australia, the U.S. and Canada that includes M.H. Carnegie & Co. and Lumira Capital. Together with the financing announced in April, the aggregate amount raised in this round is $28.5 million.

Download PDF

01
Oct

Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, announced positive top-line results from ETC-1002-008, a Phase 2b study evaluating the efficacy and safety of ETC-1002 monotherapy compared with ezetimibe monotherapy in patients with hypercholesterolemia, with or without statin intolerance.

Download PDF

0 Comments
1
1
scrollauto
Loading posts...
link_magnifier
#ffffff
on
loading
off